Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
| 1497 | 2 | CISPLATIN//ISOLATED LIMB PERFUSION//IFOSFAMIDE | 7807 |
| 11543 | 1 | CISPLATIN RESISTANCE//BUTHIONINE SULFOXIMINE//RAT OVARIAN TUMOR CELL LINES | 1000 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CISPLATIN RESISTANCE | authKW | 256499 | 6% | 13% | 61 |
| 2 | BUTHIONINE SULFOXIMINE | authKW | 148709 | 4% | 13% | 37 |
| 3 | RAT OVARIAN TUMOR CELL LINES | authKW | 131312 | 1% | 83% | 5 |
| 4 | ALKYLATOR RESISTANCE | authKW | 100847 | 0% | 80% | 4 |
| 5 | SURG RADIOL PHYS MED | address | 81032 | 1% | 43% | 6 |
| 6 | CISPLATIN | authKW | 79002 | 16% | 2% | 163 |
| 7 | APHIDICOLIN GLYCINATE | authKW | 63031 | 0% | 100% | 2 |
| 8 | BUTHIONINE SR SULFOXIMINE | authKW | 63031 | 0% | 100% | 2 |
| 9 | CIS DIAMMINE DICHLOROPLATINUMII | authKW | 63031 | 0% | 100% | 2 |
| 10 | DAMAGE RECOGNITION PROTEIN | authKW | 63031 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 16636 | 66% | 0% | 661 |
| 2 | Pharmacology & Pharmacy | 891 | 19% | 0% | 193 |
| 3 | Toxicology | 95 | 4% | 0% | 37 |
| 4 | Cell Biology | 81 | 7% | 0% | 67 |
| 5 | Medicine, Research & Experimental | 36 | 4% | 0% | 35 |
| 6 | Biochemistry & Molecular Biology | 30 | 10% | 0% | 95 |
| 7 | Biophysics | 18 | 3% | 0% | 27 |
| 8 | Obstetrics & Gynecology | 15 | 2% | 0% | 20 |
| 9 | Hematology | 12 | 2% | 0% | 19 |
| 10 | Biochemical Research Methods | 9 | 2% | 0% | 20 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | SURG RADIOL PHYS MED | 81032 | 1% | 43% | 6 |
| 2 | ANALYTICON AG | 31515 | 0% | 100% | 1 |
| 3 | ARBEITSGRP PADIAT NEUROONKOL | 31515 | 0% | 100% | 1 |
| 4 | BIJOVET | 31515 | 0% | 100% | 1 |
| 5 | CANC 0812 | 31515 | 0% | 100% | 1 |
| 6 | CANC TREATMENT EXPTL THER EUT METAB | 31515 | 0% | 100% | 1 |
| 7 | CLCC F BACLESSEEA 1772 | 31515 | 0% | 100% | 1 |
| 8 | COMITE UROGYNECOL ONCOL | 31515 | 0% | 100% | 1 |
| 9 | DANIEL DEN HOED KLINK | 31515 | 0% | 100% | 1 |
| 10 | EXPT ONCOHEMATOL | 31515 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 13615 | 6% | 1% | 57 |
| 2 | CANCER RESEARCH | 13295 | 13% | 0% | 129 |
| 3 | CANCER COMMUNICATIONS | 4936 | 0% | 4% | 4 |
| 4 | ANTICANCER RESEARCH | 4488 | 5% | 0% | 53 |
| 5 | BRITISH JOURNAL OF CANCER | 3301 | 4% | 0% | 44 |
| 6 | JAPANESE JOURNAL OF CANCER RESEARCH | 3183 | 2% | 1% | 19 |
| 7 | ANTI-CANCER DRUGS | 3026 | 2% | 1% | 18 |
| 8 | BIOCHEMICAL PHARMACOLOGY | 2929 | 4% | 0% | 42 |
| 9 | ONCOLOGY REPORTS | 1856 | 3% | 0% | 25 |
| 10 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1823 | 2% | 0% | 24 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |